SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

被引：1045

作者：

Hou, Yixuan J. ^{[1
]}

Okuda, Kenichi ^{[3
]}

Edwards, Caitlin E. ^{[1
]}

Martinez, David R. ^{[1
]}

Asakura, Takanori ^{[3
]}

Dinnon, Kenneth H., III ^{[2
]}

Kato, Takafumi ^{[3
]}

Lee, Rhianna E. ^{[3
]}

Yount, Boyd L. ^{[1
]}

Mascenik, Teresa M. ^{[3
]}

Chen, Gang ^{[3
]}

Olivier, Kenneth N. ^{[16
]}

Ghio, Andrew ^{[17
]}

Tse, Longping, V ^{[1
]}

Leist, Sarah R. ^{[1
]}

Gralinski, Lisa E. ^{[1
]}

Schafer, Alexandra ^{[1
]}

Dang, Hong ^{[3
]}

Gilmore, Rodney ^{[3
]}

Nakano, Satoko ^{[3
]}

Sun, Ling ^{[3
]}

Fulcher, M. Leslie ^{[3
]}

Livraghi-Butrico, Alessandra ^{[3
]}

Nicely, Nathan, I ^{[4
]}

Cameron, Mark ^{[11
]}

Cameron, Cheryl ^{[12
]}

Kelvin, David J. ^{[10
,18
]}

de Silva, Aravinda ^{[2
]}

Margolis, David M. ^{[2
,5
,6
]}

Markmann, Alena ^{[5
]}

Bartelt, Luther ^{[5
]}

Zumwalt, Ross ^{[13
]}

Martinez, Fernando J. ^{[14
]}

Salvatore, Steven P. ^{[15
]}

Borczuk, Alain ^{[15
]}

Tata, Purushothama R. ^{[9
]}

Sontake, Vishwaraj ^{[9
]}

Kimple, Adam ^{[7
]}

Jaspers, Ilona ^{[8
]}

O'Neal, Wanda K. ^{[3
]}

Randell, Scott H. ^{[3
]}

Boucher, Richard C. ^{[3
]}

Baric, Ralph S. ^{[1
,2
]}

机构：

[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA

[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA

[3] Univ N Carolina, Marsico Lung Inst, Chapel Hill, NC 27515 USA

[4] Univ N Carolina, Prot Express & Purificat Core, Chapel Hill, NC 27515 USA

[5] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA

[6] Univ N Carolina, HIV Cure Ctr, Chapel Hill, NC 27515 USA

[7] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC 27515 USA

[8] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA

[9] Duke Univ, Med Ctr, Dept Cell Biol, Regenerat Next Initiat, Durham, NC 27710 USA

[10] Dalhousie Univ, Canadian Ctr Vaccinol, Dept Microbiol & Immunol, Halifax, NS, Canada

[11] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA

[12] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA

[13] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA

[14] Cornell Univ, Joan & Sanford I Weill Med Coll, Div Pulm & Crit Care Med, New York, NY 10021 USA

[15] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pathol, New York, NY 10021 USA

[16] NHLBI, Lab Chron Airway Infect, Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA

[17] US EPA, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC USA

[18] Shantou Univ, Lab Immunol, Med Coll, Shantou, Guangdong, Peoples R China

来源：

CELL | 2020年 / 182卷 / 02期

关键词：

CORONAVIRUS SPIKE PROTEIN; ENZYME; 2; ACE2; SARS CORONAVIRUS; CELL ENTRY; CDNA-CLONE; MERS-COV; VIRUS; NEUTRALIZATION; ACTIVATION; ASPIRATION;

D O I：

10.1016/j.cell.2020.05.042

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The mode of acquisition and causes for the variable clinical spectrum of coronavirus disease 2019 (COVID-19) remain unknown. We utilized a reverse genetics system to generate a GFP reporter virus to explore severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis and a luciferase reporter virus to demonstrate sera collected from SARS and COVID-19 patients exhibited limited cross-CoV neutralization. High-sensitivity RNA in situ mapping revealed the highest angiotensin-converting enzyme 2 (ACE2) expression in the nose with decreasing expression throughout the lower respiratory tract, paralleled by a striking gradient of SARS-CoV-2 infection in proximal (high) versus distal (low) pulmonary epithelial cultures. COVID-19 autopsied lung studies identified focal disease and, congruent with culture data, SARS-CoV-2-infected ciliated and type 2 pneumocyte cells in airway and alveolar regions, respectively. These findings highlight the nasal susceptibility to SARS-CoV-2 with likely subsequent aspiration-mediated virus seeding to the lung in SARS-CoV-2 pathogenesis. These reagents provide a foundation for investigations into virus-host interactions in protective immunity, host susceptibility, and virus pathogenesis.

引用

页码：429 / +

页数：32

共 50 条

[41] Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens
De Pace, Vanessa
Caligiuri, Patrizia
Ricucci, Valentina
Nigro, Nicola
Galano, Barbara
Visconti, Valeria
Da Rin, Giorgio
Bruzzone, Bianca
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[42] Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Tim Flerlage
David F. Boyd
Victoria Meliopoulos
Paul G. Thomas
Stacey Schultz-Cherry
Nature Reviews Microbiology, 2021, 19 : 425 - 441
[43] Alpha and Omicron SARS-CoV-2 Adaptation in an Upper Respiratory Tract Model
Mathez, Gregory
Pillonel, Trestan
Bertelli, Claire
Cagno, Valeria
VIRUSES-BASEL, 2023, 15 (01):
[44] Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract
Liu, Zhe
Sun, Chuan-Bin
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1410 - 1412
[45] Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Flerlage, Tim
Boyd, David F.
Meliopoulos, Victoria
Thomas, Paul G.
Schultz-Cherry, Stacey
NATURE REVIEWS MICROBIOLOGY, 2021, 19 (07) : 425 - 441
[46] Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds
Lichtenstein, Moria
Turjerman, Sondra
Pinto, Jayant M.
Barash, Orna
Koren, Omry
MSYSTEMS, 2021, 6 (04)
[47] Human genetics of SARS-CoV-2 infection and critical COVID-19
Mogensen, Trine H.
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (11) : 1417 - 1421
[48] Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic
van der Velden, Alike W.
Shanyinde, Milensu
Bongard, Emily
Boehmer, Femke
Chlabicz, Slawomir
Colliers, Annelies
Garcia-Sangenis, Ana
Malania, Lile
Pauer, Jozsef
Tomacinschii, Angela
Yu, Ly-Mee
Loens, Katherine
Ieven, Margareta
Verheij, Theo J.
Goossens, Herman
Vellinga, Akke
Butler, Christopher C.
EUROPEAN JOURNAL OF GENERAL PRACTICE, 2023, 29 (01)
[49] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
Hromic-Jahjefendic, Altijana
Lundstrom, Kenneth
Adilovic, Muhamed
Aljabali, Alaa A. A.
Tambuwala, Murtaza M.
Serrano-Aroca, Angel
Uversky, Vladimir N.
AUTOIMMUNITY REVIEWS, 2024, 23 (03)
[50] The reverse zoonotic potential of SARS-CoV-2
Milich, Krista M.
Morse, Stephen S.
HELIYON, 2024, 10 (12)

← 1 2 3 4 5 →